The search frequency for Samsung Biologics, recently known as the bio business holding company of Samsung Group, has surged.

As of 1:31 PM on the 12th, Samsung Biologics' stock price rose 5.49% from the previous day to 788,000 KRW, with a trading volume of 590,828 shares, which is 165.79% of the 5-day average trading volume. Today, foreigners are tentatively recorded as net sellers of 14,000 shares of Samsung Biologics, and institutions are net sellers of 1,000 shares.

On June 10th, Samsung Biologics was an issue in the market with the headline "New high breaking 700,000 KRW due to large-scale pharmaceutical orders."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing